Our products
Cardiovascular and Metabolic diseases
Brilique® (ticagrelor) Tablets
Summary of product characteristics
Patient information leaflet (60mg)
Patient information leaflet (90mg)
ATACAND® (candesartan cilexetil) Tablets
Prescribing Information including Boxed WARNING
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) Injection
ONGLYZA® (saxagliptin) Tablets
Prescribing Information
Consumer site
Health care professional site
Oncology
ARIMIDEX® (anastrozole) Tablets
Prescribing Information
Consumer site
ATACAND® (candesartan cilexetil) Tablets
Prescribing Information including Boxed WARNING
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) Injection
ONGLYZA® (saxagliptin) Tablets
Prescribing Information
Consumer site
Health care professional site
Infection and Vaccines
ARIMIDEX® (anastrozole) Tablets
Prescribing Information
Consumer site
ATACAND® (candesartan cilexetil) Tablets
Prescribing Information including Boxed WARNING
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) Injection
ONGLYZA® (saxagliptin) Tablets
Prescribing Information
Consumer site
Health care professional site
Neuroscience
ARIMIDEX® (anastrozole) Tablets
Prescribing Information
Consumer site
ATACAND® (candesartan cilexetil) Tablets
Prescribing Information including Boxed WARNING
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) Injection
ONGLYZA® (saxagliptin) Tablets
Prescribing Information
Consumer site
Health care professional site
Respiratory
ARIMIDEX® (anastrozole) Tablets
Prescribing Information
Consumer site
ATACAND® (candesartan cilexetil) Tablets
Prescribing Information including Boxed WARNING
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) Injection
ONGLYZA® (saxagliptin) Tablets
Prescribing Information
Consumer site
Health care professional site
Gastrointestinal
ARIMIDEX® (anastrozole) Tablets
Prescribing Information
Consumer site
ATACAND® (candesartan cilexetil) Tablets
Prescribing Information including Boxed WARNING
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) Injection
ONGLYZA® (saxagliptin) Tablets
Prescribing Information
Consumer site
Health care professional site
Our focus areas
Report an adverse event
All pharmacologically effective drugs have benefits and risks. The risk may be insignificant or may be acceptable in relation to the drug's therapeutic action. Continuous monitoring of the safety of a drug throughout the duration of its use helps to ensure that its risks and benefits remain acceptable.
- AstraZeneca is committed to protecting the safety of patients who receive our products. Reporting forms and information can be found at www.imb.ie.
- All adverse events should also be reported to AstraZeneca by freephone 1800800899.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.